Abstract
The traditional definition of natural antibodies (NAbs) states that these antibodies are present prior to the body encountering cognate antigen, providing a first line of defense against infection thereby, allowing time for a specific antibody response to be mounted. The literature has a seemingly common definition of NAbs; however, as our knowledge of antibodies and B cells is refined, re-evaluation of the common definition of Nabs may be required. Defining Nabs becomes important as the function of NAb production is used to define B cell subsets (1) and as these important molecules are shown to play numerous roles in the immune system (Figure 1). Herein, we aim to briefly summarize our current knowledge of NAbs in the context of initiating a discussion within the field of how such an important and multifaceted group of molecules should be defined.
Natural Antibody (NAb) Producing Cells
Both murine and human NAbs have been discussed in detail since the late 1960s (2, 3); however, cells producing NAbs were not identified until 1983 in the murine system (4, 5). These cells, named B-1 cells, were originally identified by their expression of CD5 and were further characterized by surface expression of IgMhigh, IgDlow, CD19high, B220low, CD23−, and CD43+ (6), which contrasts with the surface phenotype of follicular B-2 cells: CD5−, IgMlow, IgDhigh, CD19+, B220+, CD23+, and CD43−. Later, an additional population of B-1 cells was identified, which shared the characteristics of CD5+ B-1 but lacked CD5 expression (7). These two populations of B-1 cells are termed B-1a (CD5+) and B-1b (CD5−) cells. B-1 cells also express CD11b; however, this expression is limited to B-1 cells residing in the body cavities and is lost upon migration to the spleen (8, 9). Furthermore, the B-1 cell population can be divided not only phenotypically but also functionally into natural or antigen-induced antibody secreting cells (10).
Figure 1
Overview of natural antibodies’ (NAbs) attributes. Graphical representation of the various NAb functions (outside green circle), epitope recognition (inside yellow circle), isotype (inside red circle), and cells shown to produce NAbs (inside blue circle).
B-1 cells are found in various tissues of adult mice, which include the peritoneal cavity, pleural cavity, spleen, bone marrow, lymph nodes, and blood [reviewed in Ref. (11)]. The tissue location may influence the functional role of B-1 cells. The peritoneal and pleural cavities have been shown to be an important reservoir for B-1 cells that respond to various stimuli (12–16) and subsequently migrate to the spleen/mesenteric or mediastinal lymph nodes, respectively, where they begin to secrete antibody (17). In mice depleted of B cells, peritoneal B-1 cells have the ability to fully reconstitute natural serum immunoglobulin (Ig) M as well as B-1 cells in all tissue locations (18); yet, in normal healthy mice, peritoneal B-1a cells do not directly contribute to natural serum IgM (19). Instead, the direct sources of natural serum IgM are B-1a cells located in the spleen and bone marrow (19). It has been shown that peritoneal B-1a cells recirculate from the peritoneum to the blood in a CXCL13-dependent manner (20). Interestingly, in the absence of CXCL13, mice are devoid of peritoneal B-1 cells but still have splenic B-1 cells; yet, despite having normal levels of serum IgM these mice have significantly less natural IgM specific for phosphorylcholine (20). This study suggests that it is possible for peritoneal B-1 cells to contribute to the splenic B-1 cell population and this recirculation might be particularly important for certain Nab reactivites. To date, the exact developmental relationship between the Nab secreting splenic/bone marrow B-1a cells and peritoneal B-1a cells is still unknown.
Beyond heterogeneity at different tissue sites, various subpopulations of B-1a cells have been defined based on surface marker expression. In the peritoneal cavity, B-1a subpopulations include PD-L2 (PD-L2+/−) (21, 22), CD25 (CD25+/−) (23), CD73 (CD73hi/lo) (24), and PC-1 (PC-1hi/lo). The PD-L2, CD25, and CD73 subsets showed no difference in the amount of natural IgM secretion between positive and negative subsets (21–24). Conversely, PC-1 B-1a cell subsets differed in the level of natural IgM secretion. PC-1lo B-1a cells were shown to produce the large majority of natural IgM (25). PC-1hi B-1a cells produced a significantly lower level of natural IgM and contained B-1a cells producing the antiphosphatidylcholine (anti-PtC) specificity (25, 26). B-1a cells have also been shown to produce IL-10 in the absence of stimulation (27); however, the relationship between regulatory (B10) cells (28) and B-1a cells is still unknown. In the bone marrow, a fetal-derived B cell subset was recently identified, which phenotypes as a plasmablast/plasma cell (CD5−IgM+IgD−CD138+B220lo/−FSChiCD43+) (29); it is unknown whether this population is a terminally differentiated B-1, B-2, or novel population of cells (19). In the spleen, a population of CD138 + B-1a cells is present in unimmunized mice, which rapidly respond to stimulation prior to immigration of peritoneal B-1 cells to the spleen (30). The spleen is also home to marginal zone B cells, which also produce NAbs (31); however, it has been demonstrated that greater than 90% of Nab is produced by B-1 cells (18).
Given the evidence described previously, it is clear in mice, more than one B cell population is responsible for NAb production and not all subsets of B-1 cells spontaneously secrete NAbs that accumulate in serum. Thus, the generalization that all B-1 cells secrete NAbs should be avoided. This point has important implications when comparing the molecular repertoire of a certain B-1 cell subset as it relates to the total natural serum IgM repertoire, which would include the molecular repertoire of numerous B-1 cell subsets from various locations (10).
Natural antibody secreting cells in humans were first identified as CD5+ peripheral B cells (32–35). Later, it was demonstrated that CD5−CD45RAlo peripheral B cells could also produce natural IgM (36). Much of the early work in humans focused on characterization and comparison of polyreactive antibodies, which were shown to utilize VH4 more frequently than monoreactive antibodies (37). More recently, strides have been made to refine the phenotypic characterization of Nab producing cells in the human system by starting with functional characteristics such as natural/spontaneous antibody secretion. This approach yielded a new phenotypic definition, CD20+CD27+CD43+CD70−CD38mod, of Nab secreting cells, the majority of which express CD5 (1, 38). Nevertheless, the phenotype of antibody secreting cells in the peripheral blood of humans is still evolving. Further investigation of Nab secreting cells in the human system is needed to elucidate the specific types of cells that are capable of producing NAbs, as well as the location of these cells beyond peripheral blood.
NAb Reactivity
Although NAbs are known for their broad reactivity against self-antigens, some have the ability to recognize evolutionarily fixed epitopes present in foreign antigens. Whether or not NAb recognition of foreign structures is always the result of cross-reactivity against self-antigens is still a matter of debate. Generally, the most well-characterized epitopes to date include phospholipids, oxidized lipids, glycolipids, and glycoproteins. The best characterized B-1 cell-derived NAb binds the phospholipid phosphorylcholine and utilizes VHS107.1 (39). Phosphorylcholine is found within the bacterial cell wall of Streptococcus pneumoniae (40) and is also exposed on apoptotic cells and oxidized lipids (41–45). In normal healthy cells, phosphorylcholine is hidden within the head group of another well-characterized NAb epitope, PtC. PtC is a normal constituent of cell membranes, which is exposed upon treatment with the protease, bromelain (46–49). Early studies revealed NAb binding to red blood cells treated with bromelain were B-1 cell derived and utilized VH11 (50, 51), VH12 (52), and Q52 (53).
Antibodies that recognize glycan epitopes are also highly abundant in both mice and humans (54, 55). Glycan epitopes are observed on both glycoproteins and glycolipids and can be present in autologous or pathogen-associated exogenous structures. In mice, the specificities of such antibodies are thoroughly reviewed by New et al., which include alpha-1,3-glucan, N-acetyl-d-glucosamine, and alpha-1,3-galactose epitopes (56). In humans, the best known antiglycan antibodies react with blood group antigens A and B (57), the xenoantigen Gal-alpha-1,3Gal-beta-1,4GlcNAc (58, 59), Forssman glycolipid antigen, and gangliosides such as the tumor-associated antigen Neu5GcGM3 (60).
NAb Functions
Natural antibodies provide various essential functions within the immune system. The most prevalently studied function is the ability to provide protection against bacterial, viral, and fungal infections. Such protection is afforded by Nabs’ epitope recognition. In particular, NAbs have been shown to provide protection against S. pneumoniae (61–63), sepsis (64), Borrelia hermsii (65), influenza virus (66), Listeria monocytogenes (67), vesicular stomatitis virus (67), lymphocytic choriomeningitis virus (67), Cryptococcus neoformans (68), and Pneumocystis murina (69). In addition to Nabs to the aforementioned organisms, B-1 cells produce “induced” antibody responses against S. pneumoniae (61), B. hermsii (65, 70, 71), influenza virus (12, 66, 72), and Francisella tularensis (13, 73).
Beyond protection against various infections, NAbs serve a number of other essential functions in the immune system. These functions have been reviewed extensively elsewhere (56) and include regulation of B cell development (10, 74, 75), selection of the B cell repertoire (74, 76), regulation of B cell responses (77), clearance of apoptotic debris (45), vascular homeostasis/protection against atherosclerosis (78–81), allergic suppression (82, 83), and protection from cancer (84, 85) (Figure 1). Despite this broad range of identified NAb functions, the role of NAbs in the immune system continues to expand.
NAb Characteristics
In mice, typical characteristics of NAbs include germline-like nucleotide structure, repertoire skewing, IgM, IgA, or IgE (86) isotype, and T cell independence. Classically, NAbs are defined as being germline like as evidenced by these antibodies lacking non-templated nucleotides (N-additions) and having little to no somatic hypermutation (39, 87, 88). Antigen receptor diversity is increased during VDJ recombination when the enzyme TdT is present, which adds N-additions to the V-D and D-J junctions (89). Such germline characteristics have been shown to be essential in NAbs’ ability to protect against infection. The prototypical B-1a anti-phosphorylcholine antibody, T15, has no N-addition (90, 91). In mice with forced expression of TdT, all anti-PC antibodies generated after vaccination with heat killed S. pneumoniae contain N-additions; however, these anti-phosphorylcholine antibodies containing N-additions were shown to provide no protection against S. pneumoniae infection (92). This study highlights the importance of germline structure in the protection provided by evolutionarily conserved Nab. In addition, NAbs derived from murine B-1a cells have a restricted repertoire. On average 5–15% of peritoneal B-1a cells recognize PtC and utilize VH11 and VH12 (93).
Other studies have shown that these “classical” characteristics of NAbs do not always apply. For instance, B-1a cells from 6- to 24-month-old mice produce Igs with significantly more N-additions (94, 95). Furthermore, it was demonstrated that B-1a cells accumulate somatic hypermutations with increasing age, which is AID dependent (96). In this same study, isotype switching was also increased in B-1a cells with age (96). Nonetheless, throughout the decades of Nab investigation, IgG and IgA have been shown to be present within the NAb pool (97–99); however, natural IgG and IgA levels decrease significantly in germ-free mice, whereas IgM levels remain unaffected (100). This suggests the amount of natural serum IgG and IgA are dependent upon exogenous antigen stimulation, whereas the level of natural serum IgM is not.
In humans, studying NAbs in the absence of antigen exposure is a challenge; however, studies performed during early human life provide a period of limited exogenous antigen exposure in the presence of undistributed, strictly controlled intrauterine antigen milieu (101). It was demonstrated that inside the fetal B cell population at 12–14 weeks of human gestation, only IgM and IgD transcripts were detected (101). Yet, after 26 weeks of gestation, B cell clones encoding IgG start to appear in a frequency similar to a frequency observed in healthy infants, which suggests IgM is not the only isotype present in the prenatal repertoire of human B cells. Furthermore, somatic hypermutations occur during human fetal B cell development even in a T cell-independent fashion (101). As described in mice, early human NAbs are also diverse in isotype and structure.
Non-templated nucleotides (junctional diversity) are also an important mechanism of generating Ig structural diversity, which along with combinatorial diversity and somatic mutation results in numerous Ig specificities (102–104). In mice, natural B-1a cell-derived IgM is characterized by a low number of N-additions (105). Interestingly, TdT expression is restricted to adult life in mice (89), which is after the majority of fetal derived B-1a cell development has occurred (105, 106). Therefore, in mice, fetal-derived B-1a cells lack N-additions (106), whereas adult bone marrow-derived B-1a cells display a high level of N-additions (95, 107–109). In contrast, TdT is expressed during both fetal and adult life in humans, and as a result, both fetal and adult derived human B cells express Ig with numerous N-additions (110). Yet, it has been shown human and mouse fetal sequences share both similarities and differences in their repertories (111). For example, even though TdT is present throughout early human life, it has been demonstrated that the number of N-additions/CDR-H3 length in B cells from preterm and term infants are shorter than that of adults (112).
Defining NAbs
As one reads through the body of NAb literature from the early 1960s to the present day, it becomes increasingly difficult to find a common concrete definition. The most frequently used definition describes NAbs as preimmune antibodies generated in the absence of exogenous antigenic stimulation, which are non-specific, broadly cross-reactive, low affinity, germline-like antibodies. As summarized in Figure 1, NAbs have many attributes, although NAbs cannot be defined by several of these characteristics. Furthermore, NAbs cannot be defined based on a single B cell subset or location. Different subsets of B cells in different locations are capable of secreting NAbs. Neither a specific isotype nor a specific function can define NAbs. Therefore, the characteristics left to define NAbs include how they are generated (presence or absence of endogenous and/or exogenous antigen) and their structural composition (germline-like or diverse).
In terms of specific reactivity to exogenous antigens, studies have indicated that B-1a cells in the peritoneal cavity serve as a long-term reservoir of “natural” antibody-producing cells after first exposure to the antigen (17). However, if these B-1 cells have previously seen their cognate antigen it might be more appropriate to term these as memory B-1 cells. In fact, some subsets of peritoneal B-1a cells share similarities to memory B cells such as PD-L2 and CD73 expression (21, 24). Thus, it has been suggested that within the B-1 cell population, those residing in the bone marrow and the spleen are the true Nab-secreting cells (17), whereas body cavity B-1 cells constitute a population of responder (memory type) lymphocytes, which after stimulation migrate and differentiate to IgM-secreting cells. As such, it is possible body cavity B-1 cells should not be considered NAb secretors since intentional stimulation is required to upregulate the secreting process.
Other studies indicate exogenous antigens are required for selection of the overall B cell repertoire (76). In addition, altering antigenic exposure during neonatal life has been shown to significantly change the repertoire of adult B cells (82). B-1a cells are generated mainly during the fetal/neonatal period; therefore, any antigen exposure during neonatal life would be expected to significantly influence the development of B-1a cell-derived NAbs. Interestingly, it has been suggested that the neonatal period is subject to increased intestinal permeability and this access point for antigen exposure could direct the development of NAbs (56). Nonetheless, no significant difference was observed between the B-1a cell derived IgM repertoire in germ-free mice when compared with specific pathogen-free mice (96, 98, 113, 114). In adult humans, the issue of antigen exposure is more of a problem as the antigenic exposure of humans cannot be controlled; therefore, studying a pre-immune repertoire is nearly impossible.
Schroeder and colleagues demonstrated the importance of both endogenous self-antigens and germline structure of antibodies in shaping the NAb repertoire. They showed the ability of the T15 NAb to clear endogenous antigen (oxidized low-density lipoprotein) is only dependent upon selection driven by self-antigens regardless of germline antibody structure, whereas the effectiveness of T15 to protect against exogenous antigen (phosphorylcholine/S. pneumoniae) is dependent upon both germline conservation and selection by self-antigen (115, 116). This is in line with studies by Kearney et al. demonstrating the influence of exogenous antigen upon the effectiveness of anti-phosphorylcholine antibody against S. pneumonia versus allergy (82). Together, these studies demonstrate how endogenous antigen, exogenous antigen, and germline composition create and alter the NAb repertoire.
Overall, these NAb studies call into question how Nabs can/should be accurately defined. Recently, this point has been plainly discussed in two separate reviews. The first by Baumgarth et al. (17), suggests an explicit definition: “we suggest the term natural IgM production be restricted to the truly antigen-independent elaboration of IgM in the spleen and bone marrow and not be extended to antigen-induced responses by B-1 cells.” The second by New et al. (56) states: “Thus, the generalization often made that the NAb repertoire develops independently of exogenous is not universal for all NAb specificities, and further research focusing on the factors contributing to the development and the composition of the NAb repertoire is warranted.” Herein, we suggest that these seemingly separate points of view can find common ground with further investigation.
It is clear a NAb repertoire can be created in the absence of exogenous antigens and/or germinal center maturation, and perhaps this is the definition of NAbs in its purest form. Yet, it has also been demonstrated that NAbs are affected by the presence of exogenous antigen, which is encountered in normal functioning systems. As an attempt to incorporate the role of antigen in the NAb repertoire, we propose the following starting point for investigation. To be a NAb, two requirements are necessary: (1) the ability to exert a protective, regulatory, or other biological function and (2) pre-existing/immediately responsive antibody. In the first requirement, the biological function might be protective, regulatory, or provide a function yet to be elucidated. In the second requirement, the antibody must already be present and secreted, or the NAb encoding cell would need only a light push1 for the NAb to be secreted.2 The role of antigen comes into play when considering the light push that some NAb secreting cells might need to immediately produce antibody. Furthermore, the ability of the NAb encoding cell to respond to the light push would be dependent upon its intrinsic properties such as status of surface phenotype or activation threshold. Further experimentation is required to determine whether the NAb produced by NAb secreting cells needing antigen exposure to immediately produce antibody differs from antibodies produced by other cells capable of immediate production of antibody (i.e., memory cells) (Figure 2). It is these authors perspective, as a field studying this clearly essential part of the immune system, we need to further investigate all contexts in which NAbs are produced and regulated (Figure 2).
Figure 2
Determining how to define natural antibodies (NAbs). (1) Most frequently used definition of NAbs: preimmune antibodies generated in the absence of exogenous antigenic stimulation, which are broadly reactive, low affinity, germline-like antibodies selected in the presence of endogenous antigen (depicted in green). These antibodies are pre-existing/always present in the serum. The dotted outline represents the intrinsic properties the cell might have (e.g., increased levels of IgM and/or CD86/CD80, lower activation threshold). The dark outline indicates the cell is secreting Ig. (2–4) In panels 2–4, we suggest possible antigenic experiences of NAbs; however, further investigation is required to determine whether antibodies produced after such antigenic experiences are the same as preimmune, pre-existing NAbs in terms of germline structure and/or repertoire. (2) Here, we suggest a NAb producing cell may require an extra antigen experience (light push(1)) to start immediately (within hours) secreting. This antigen experience contrasts the strong activation required for naive B-2 cells (depicted in red) to differentiate into plasma cells (PC), which results in highly specific non-germline antibody (depicted in blue). However, it is unknown what affect this light push might have upon the antibody produced by the NAb producing cell (this is depicted by giving the cell both blue and green antibody colors). (3) We suggest a NAb producing cell that is already secreting NAbs experiences antigen, which induces differentiation into a plasma cell (PC). Again, it is unknown what affect this differentiation might have upon the antibody produced (this is depicted by giving the cell both blue and green antibody colors). (4) Finally, we depict NAb producing cells experiencing strong/specific activation and subsequently following the traditional pathway leading to memory and plasma cell differentiation.
Statements
Author contributions
All authors contributed to the writing and development of the perspective put forth. All authors worked together to edit and revise the manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Footnotes
1.^We are suggesting a light push to mean exposure to antigen or other stimuli leading to a differentiation pathway operating outside of the strong stimuli provided by the germinal center environment and thus, different from the naive B-2 cell requirement for stimulation.
2.^The subset of Nab-producing cells needing a light push might be poised to secrete but are not detected as such by the methods currently available.
References
1
GriffinDOHolodickNERothsteinTL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70. J Exp Med (2011) 208:67–80.10.1084/jem.201014992084c
2
BoydenSV. Natural antibodies and the immune response. Adv Immunol (1966) 5:1–28.10.1016/S0065-2776(08)60271-0
3
MichaelJG. Natural antibodies. Curr Top Microbiol Immunol (1969) 48:43–62.
4
HayakawaKHardyRRParksDRHerzenbergLA. The “Ly-1 B” cell subpopulation in normal immunodefective, and autoimmune mice. J Exp Med (1983) 157:202–18.10.1084/jem.157.1.202
5
HayakawaKHardyRRHondaMHerzenbergLASteinbergADHerzenbergLA. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci U S A (1984) 81:2494–8.10.1073/pnas.81.8.2494
6
BaumgarthN. B-cell immunophenotyping. Methods Cell Biol (2004) 75:643–62.10.1016/S0091-679X(04)75027-X
7
KantorABStallAMAdamsSHerzenbergLAHerzenbergLA. Differential development of progenitor activity for three B-cell lineages. Proc Natl Acad Sci U S A (1992) 89:3320–4.10.1073/pnas.89.8.3320
8
GhosnEEYangYTungJHerzenbergLAHerzenbergLA. CD11b expression distinguishes sequential stages of peritoneal B-1 development. Proc Natl Acad Sci U S A (2008) 105:5195–200.10.1073/pnas.0712350105
9
HastingsWDGurdakSMTumangJRRothsteinTL. CD5+/Mac-1-peritoneal B cells: a novel B cell subset that exhibits characteristics of B-1 cells. Immunol Lett (2006) 105:90–6.10.1016/j.imlet.2006.01.002
10
BaumgarthN. B-1 cell heterogeneity and the regulation of natural and antigen-induced IgM production. Front Immunol (2016) 7:324.10.3389/fimmu.2016.00324
11
BaumgarthN. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol (2011) 11:34–46.10.1038/nri2901
12
ChoiYSBaumgarthN. Dual role for B-1a cells in immunity to influenza virus infection. J Exp Med (2008) 205:3053–64.10.1084/jem.20080979
13
ColeLEYangYElkinsKLFernandezETQureshiNShlomchikMJet alAntigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge. Proc Natl Acad Sci U S A (2009) 106:4343–8.10.1073/pnas.0813411106
14
KawaharaTOhdanHZhaoGYangYGSykesM. Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells. J Immunol (2003) 171:5406–14.10.4049/jimmunol.171.10.5406
15
WatanabeNIkutaKFagarasanSYazumiSChibaTHonjoT. Migration and differentiation of autoreactive B-1 cells induced by activated gamma/delta T cells in antierythrocyte immunoglobulin transgenic mice. J Exp Med (2000) 192:1577–86.10.1084/jem.192.11.1577
16
WaffarnEEHasteyCJDixitNSoo ChoiYCherrySKalinkeUet alInfection-induced type I interferons activate CD11b on B-1 cells for subsequent lymph node accumulation. Nat Commun (2015) 6:8991.10.1038/ncomms9991
17
BaumgarthNWaffarnEENguyenTT. Natural and induced B-1 cell immunity to infections raises questions of nature versus nurture. Ann N Y Acad Sci (2015) 1362:188–99.10.1111/nyas.12804
18
LalorPAHerzenbergLAAdamsSStallAM. Feedback regulation of murine Ly-1 B cell development. Eur J Immunol (1989) 19:507–13.10.1002/eji.1830190315
19
SavageHPBaumgarthN. Characteristics of natural antibody-secreting cells. Ann N Y Acad Sci (2015) 1362:132–42.10.1111/nyas.12799
20
AnselKMHarrisRBCysterJG. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity (2002) 16:67–76.10.1016/S1074-7613(01)00257-6
21
ZhongXTumangJRGaoWBaiCRothsteinTL. PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding. Eur J Immunol (2007) 37:2405–10.10.1002/eji.200737461
22
ZhongXLauSBaiCDegauqueNHolodickNEStevenSJet alA novel subpopulation of B-1 cells is enriched with autoreactivity in normal and lupus-prone mice. Arthritis Rheum (2009) 60:3734–43.10.1002/art.25015
23
TumangJRHolodickNEVizcondeTCKakuHFrancesRRothsteinTL. A CD25(−) positive population of activated B1 cells expresses LIFR and responds to LIF. Front Immunol (2011) 2:6.10.3389/fimmu.2011.00006
24
KakuHChengKFAl-AbedYRothsteinTL. A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production. J Immunol (2014) 193:5904–13.10.4049/jimmunol.1400336
25
WangHShinDMAbbasiSJainSKovalchukALBeatyNet alExpression of plasma cell alloantigen 1 defines layered development of B-1a B-cell subsets with distinct innate-like functions. Proc Natl Acad Sci U S A (2012) 109:20077–82.10.1073/pnas.1212428109
26
WangHLinJXLiPSkinnerJLeonardWJMorseHCIII. New insights into heterogeneity of peritoneal B-1a cells. Ann N Y Acad Sci (2015) 1362:68–76.10.1111/nyas.12791
27
O’GarraAChangRGoNHastingsRHaughtonGHowardM. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol (1992) 22:711–7.10.1002/eji.1830220314
28
BouazizJDYanabaKTedderTF. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev (2008) 224:201–14.10.1111/j.1600-065X.2008.00661.x
29
ReynoldsAEKuraokaMKelsoeG. Natural IgM is produced by CD5− plasma cells that occupy a distinct survival niche in bone marrow. J Immunol (2015) 194:231–42.10.4049/jimmunol.1401203
30
YangYTungJWGhosnEEHerzenbergLAHerzenbergLA. Division and differentiation of natural antibody-producing cells in mouse spleen. Proc Natl Acad Sci U S A (2007) 104:4542–6.10.1073/pnas.0700001104
31
IchikawaDAsanoMShintonSABrill-DashoffJFormicaAMVelcichAet alNatural anti-intestinal goblet cell autoantibody production from marginal zone B cells. J Immunol (2015) 194:606–14.10.4049/jimmunol.1402383
32
CasaliPNotkinsAL. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today (1989) 10:364–8.10.1016/0167-5699(89)90268-5
33
AntinJHEmersonSGMartinPGadolNAultKA. Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies. J Immunol (1986) 136:505–10.
34
KippsTJFongSTomhaveEChenPPGoldfienRDCarsonDA.High-frequency expression of a conserved kappa light-chain variable-region gene in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (1987) 84:2916–20.10.1073/pnas.84.9.2916
35
CasaliPBurasteroSENakamuraMInghiramiGNotkinsAL. Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science (1987) 236:77–81.10.1126/science.3105056
36
KasaianMTIkematsuHCasaliP. Identification and analysis of a novel human surface CD5− B lymphocyte subset producing natural antibodies. J Immunol (1992) 148:2690–702.
37
CasaliPSchettinoEW. Structure and function of natural antibodies. Curr Top Microbiol Immunol (1996) 210:167–79.
38
QuachTDRodriguez-ZhurbenkoNHopkinsTJGuoXHernandezAMLiWet alDistinctions among circulating antibody-secreting cell populations, including B-1 cells, in human adult peripheral blood. J Immunol (2016) 196:1060–9.10.4049/jimmunol.1501843
39
FeeneyAJ. Predominance of the prototypic T15 anti-phosphorylcholine junctional sequence in neonatal pre-B cells. J Immunol (1991) 147:4343–50.
40
BrundishDEBaddileyJ. Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate. Biochem J (1968) 110:573–82.10.1042/bj1100573
41
ShawPXHorkkoSChangMKCurtissLKPalinskiWSilvermanGJet alNatural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest (2000) 105:1731–40.10.1172/JCI8472
42
BinderCJHorkkoSDewanAChangMKKieuEPGoodyearCSet alPneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med (2003) 9:736–43.10.1038/nm876
43
ChenYParkYBPatelESilvermanGJ. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J Immunol (2009) 182:6031–43.10.4049/jimmunol.0804191
44
ChouMYFogelstrandLHartvigsenKHansenLFWoelkersDShawPXet alOxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest (2009) 119:1335–49.10.1172/JCI36800
45
GronwallCVasJSilvermanGJ. Protective roles of natural IgM antibodies. Front Immunol (2012) 3:66.10.3389/fimmu.2012.00066
46
CunninghamAJ. Large numbers of cells in normal mice produce antibody components of isologous erythrocytes. Nature (1974) 252:749–51.10.1038/252749a0
47
LordEMDuttonRW. The properties of plaque-forming cells from autoimmune and normal strains of mice with specificity for autologous erythrocyte antigens. J Immunol (1975) 115:1199–205.
48
CoxKOHardySJ. Autoantibodies against mouse bromelain-modified RBC are specifically inhibited by a common membrane phospholipid, phosphatidylcholine. Immunology (1985) 55:263–9.
49
MercolinoTJArnoldLWHaughtonG. Phosphatidyl choline is recognized by a series of Ly-1+ murine B cell lymphomas specific for erythrocyte membranes. J Exp Med (1986) 163:155–65.10.1084/jem.163.1.155
50
ReiningerLOllierPPoncetPKaushikAJatonJC. Novel V genes encode virtually identical variable regions of six murine monoclonal anti-bromelain-treated red blood cell autoantibodies. J Immunol (1987) 138:316–23.
51
HardyRRCarmackCEShintonSARibletRJHayakawaK. A single VH gene is utilized predominantly in anti-BrMRBC hybridomas derived from purified Ly-1 B cells. Definition of the VH11 family. J Immunol (1989) 142:3643–51.
52
PennellCASheehanKMBrodeurPHClarkeSH. Organization and expression of VH gene families preferentially expressed by Ly-1+ (CD5) B cells.Eur J Immunol (1989) 19:2115–21.10.1002/eji.1830191122
53
SeidlKJMacKenzieJDWangDKantorABKabatEAHerzenbergLAet alFrequent occurrence of identical heavy and light chain Ig rearrangements. Int Immunol (1997) 9:689–702.10.1093/intimm/9.5.689
54
DaiHZhangYLvPGaoXM. A study on the glycan specificity of natural antibody repertoires in rodents. Cell Mol Immunol (2009) 6:453–9.10.1038/cmi.2009.57
55
HuflejtMEVuskovicMVasiliuDXuHObukhovaPShilovaNet alAnti-carbohydrate antibodies of normal sera: findings, surprises and challenges. Mol Immunol (2009) 46:3037–49.10.1016/j.molimm.2009.06.010
56
NewJSKingRGKearneyJF. Manipulation of the glycan-specific natural antibody repertoire for immunotherapy. Immunol Rev (2016) 270:32–50.10.1111/imr.12397
57
ShilovaNHuflejtMEVuskovicMObukhovaPNavakouskiMKhasbiullinaNet alNatural antibodies against sialoglycans. Top Curr Chem (2015) 366:169–81.10.1007/128_2013_469
58
McKaneWLeeJPrestonRHackingASimpsonPLyndsSet alPolymorphism in the human anti-pig natural antibody repertoire: implications for antigen-specific immunoadsorption. Transplantation (1998) 66:626–33.10.1097/00007890-199809150-00014
59
GaliliU. Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits. Immunology (2013) 140:1–11.10.1111/imm.12110
60
Rodriguez-ZhurbenkoNMartinezDBlancoRRondonTGrinanTHernandezAM. Human antibodies reactive to NeuGcGM3 ganglioside have cytotoxic antitumor properties. Eur J Immunol (2013) 43:826–37.10.1002/eji.201242693
61
HaasKMPoeJCSteeberDATedderTF. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity (2005) 23:7–18.10.1016/j.immuni.2005.04.011
62
BrilesDENahmMSchroerKDavieJBakerPKearneyJet alAntiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J Exp Med (1981) 153:694–705.10.1084/jem.153.3.694
63
MiQSZhouLSchulzeDHFischerRTLustigARezankaLJet alHighly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse. Proc Natl Acad Sci U S A (2000) 97:6031–6.10.1073/pnas.110039497
64
BoesMProdeusAPSchmidtTCarrollMCChenJ. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med (1998) 188:2381–6.10.1084/jem.188.12.2381
65
AlugupalliKRGersteinRMChenJSzomolanyi-TsudaEWoodlandRTLeongJM. The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J Immunol (2003) 170:3819–27.10.4049/jimmunol.170.7.3819
66
BaumgarthNHermanOCJagerGCBrownLHerzenbergLAHerzenbergLA. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci U S A (1999) 96:2250–5.10.1073/pnas.96.5.2250
67
OchsenbeinAFFehrTLutzCSuterMBrombacherFHengartnerHet alControl of early viral and bacterial distribution and disease by natural antibodies. Science (1999) 286:2156–9.10.1126/science.286.5447.2156
68
SubramaniamKSDattaKQuinteroEManixCMarksMSPirofskiLA. The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J Immunol (2010) 184:5755–67.10.4049/jimmunol.0901638
69
RapakaRRRicksDMAlcornJFChenKKhaderSAZhengMet alConserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina. J Exp Med (2010) 207:2907–19.10.1084/jem.20100034
70
AlugupalliKRLeongJMWoodlandRTMuramatsuMHonjoTGersteinRM. B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity (2004) 21:379–90.10.1016/j.immuni.2004.06.019
71
ColomboMJAlugupalliKR. Complement factor H-binding protein, a putative virulence determinant of Borrelia hermsii, is an antigenic target for protective B1b lymphocytes. J Immunol (2008) 180:4858–64.10.4049/jimmunol.180.7.4858
72
BaumgarthNHermanOCJagerGCBrownLEHerzenbergLAChenJ. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med (2000) 192:271–80.10.1084/jem.192.2.271
73
YangYGhosnEEColeLEObukhanychTVSadate-NgatchouPVogelSNet alAntigen-specific antibody responses in B-1a and their relationship to natural immunity. Proc Natl Acad Sci U S A (2012) 109:5382–7.10.1073/pnas.1121631109
74
NguyenTTElsnerRABaumgarthN. Natural IgM prevents autoimmunity by enforcing B cell central tolerance induction. J Immunol (2015) 194:1489–502.10.4049/jimmunol.1401880
75
NguyenTTKlasenerKZurnCCastilloPABrust-MascherIImaiDMet alThe IgM receptor FcmuR limits tonic BCR signaling by regulating expression of the IgM BCR. Nat Immunol (2017) 18:321–33.10.1038/ni.3677
76
FreitasAAVialeACSundbladAHeusserCCoutinhoA. Normal serum immunoglobulins participate in the selection of peripheral B-cell repertoires. Proc Natl Acad Sci U S A (1991) 88:5640–4.10.1073/pnas.88.13.5640
77
BoesMEsauCFischerMBSchmidtTCarrollMChenJ. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol (1998) 160:4776–87.
78
TsiantoulasDDiehlCJWitztumJLBinderCJ. B cells and humoral immunity in atherosclerosis. Circ Res (2014) 114:1743–56.10.1161/CIRCRESAHA.113.301145
79
ZhangMAlicotEMChiuILiJVernaNVorup-JensenTet alIdentification of the target self-antigens in reperfusion injury. J Exp Med (2006) 203:141–52.10.1084/jem.20050390
80
BinderCJShawPXChangMKBoullierAHartvigsenKHorkkoSet alThe role of natural antibodies in atherogenesis. J Lipid Res (2005) 46:1353–63.10.1194/jlr.R500005-JLR200
81
BinderCJSilvermanGJ. Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin Immunopathol (2005) 26:385–404.10.1007/s00281-004-0185-z
82
KearneyJFPatelPStefanovEKKingRG. Natural antibody repertoires: development and functional role in inhibiting allergic airway disease. Annu Rev Immunol (2015) 33:475–504.10.1146/annurev-immunol-032713-120140
83
PatelPSKearneyJF. Neonatal exposure to pneumococcal phosphorylcholine modulates the development of house dust mite allergy during adult life. J Immunol (2015) 194:5838–50.10.4049/jimmunol.1500251
84
VollmersHPBrandleinS. Natural antibodies and cancer. N Biotechnol (2009) 25:294–8.10.1016/j.nbt.2009.03.016
85
MadiABransburg-ZabarySMaayan-MetzgerADarGBen-JacobECohenIR. Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera. J Immunol (2015) 194:5272–81.10.4049/jimmunol.1402771
86
McCoyKDHarrisNLDienerPHatakSOdermattBHangartnerLet alNatural IgE production in the absence of MHC class II cognate help. Immunity (2006) 24:329–39.10.1016/j.immuni.2006.01.013
87
TornbergUCHolmbergD. B-1a, B-1b and B-2 B cells display unique VHDJH repertoires formed at different stages of ontogeny and under different selection pressures. EMBO J (1995) 14:1680–9.
88
KantorABMerrillCEHerzenbergLAHillsonJL. An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J Immunol (1997) 158:1175–86.
89
DesiderioSVYancopoulosGDPaskindMThomasEBossMALandauNet alInsertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells. Nature (1984) 311:752–5.10.1038/311752a0
90
BrilesDEFormanCHudakSClaflinJL. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med (1982) 156:1177–85.10.1084/jem.156.4.1177
91
BenedictCLGilfillanSThaiTHKearneyJF. Terminal deoxynucleotidyl transferase and repertoire development. Immunol Rev (2000) 175:150–7.10.1111/j.1600-065X.2000.imr017518.x
92
BenedictCLKearneyJF. Increased junctional diversity in fetal B cells results in a loss of protective anti-phosphorylcholine antibodies in adult mice. Immunity (1999) 10:607–17.10.1016/S1074-7613(00)80060-6
93
MercolinoTJArnoldLWHawkinsLAHaughtonG. Normal mouse peritoneum contains a large population of Ly-1+ (CD5) B cells that recognize phosphatidyl choline. Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes. J Exp Med (1988) 168:687–98.10.1084/jem.168.2.687
94
ForsterIGuHRajewskyK. Germline antibody V regions as determinants of clonal persistence and malignant growth in the B cell compartment. EMBO J (1988) 7:3693–703.
95
HolodickNEVizcondeTHopkinsTJRothsteinTL. Age-related decline in natural IgM function: diversification and selection of the B-1a cell pool with age. J Immunol (2016) 196:4348–57.10.4049/jimmunol.1600073
96
YangYWangCYangQKantorABChuHGhosnEEet alDistinct mechanisms define murine B cell lineage immunoglobulin heavy chain (IgH) repertoires. Elife (2015) 4:e09083.10.7554/eLife.09083
97
AvrameasS. Natural autoantibodies: from ‘horror autotoxicus’ to ‘gnothi seauton’. Immunol Today (1991) 12:154–9.10.1016/0167-5699(91)90080-D
98
CoutinhoAKazatchkineMDAvrameasS. Natural autoantibodies. Curr Opin Immunol (1995) 7:812–8.10.1016/0952-7915(95)80053-0
99
IkematsuHSchettinoEWCasaliP. Structure of the VH-D-JH segments of human natural polyreactive IgM and IgG antibodies. Use of germline or somatically mutated forms of commonly expressed VH genes. Ann N Y Acad Sci (1995) 764:362–9.10.1111/j.1749-6632.1995.tb55848.x
100
HooijkaasHBennerRPleasantsJRWostmannBS. Isotypes and specificities of immunoglobulins produced by germ-free mice fed chemically defined ultrafiltered “antigen-free” diet. Eur J Immunol (1984) 14:1127–30.10.1002/eji.1830141212
101
RechaviELevALeeYNSimonAJYinonYLipitzSet alTimely and spatially regulated maturation of B and T cell repertoire during human fetal development. Sci Transl Med (2015) 7:276ra225.10.1126/scitranslmed.aaa0072
102
TonegawaS. Somatic generation of antibody diversity. Nature (1983) 302:575–81.10.1038/302575a0
103
AltFWBaltimoreD. Joining of immunoglobulin heavy chain gene segments: implications from a chromosome with evidence of three D-JH fusions. Proc Natl Acad Sci U S A (1982) 79:4118–22.10.1073/pnas.79.13.4118
104
XuJLDavisMM. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity (2000) 13:37–45.10.1016/S1074-7613(00)00006-6
105
FeeneyAJ. Lack of N regions in fetal and neonatal mouse immunoglobulin V-D-J junctional sequences. J Exp Med (1990) 172:1377–90.10.1084/jem.172.5.1377
106
KantorAB. V-gene usage and N-region insertions in B-1a, B-1b and conventional B cells. Semin Immunol (1996) 8:29–35.10.1006/smim.1996.0005
107
HolodickNERepetnyKZhongXRothsteinTL. Adult BM generates CD5+ B1 cells containing abundant N-region additions. Eur J Immunol (2009) 39:2383–94.10.1002/eji.200838920
108
DuberSHafnerMKreyMLienenklausSRoyBHobeikaEet alInduction of B-cell development in adult mice reveals the ability of bone marrow to produce B-1a cells. Blood (2009) 114:4960–7.10.1182/blood-2009-04-218156
109
EsplinBLWelnerRSZhangQBorghesiLAKincadePW. A differentiation pathway for B1 cells in adult bone marrow. Proc Natl Acad Sci U S A (2009) 106:5773–8.10.1073/pnas.0811632106
110
AsmaGEvan den BerghRLVossenJM. Characterization of early lymphoid precursor cells in the human fetus using monoclonal antibodies and anti-terminal deoxynucleotidyl transferase. Clin Exp Immunol (1986) 64:356–63.
111
SchroederHWJr. Similarity and divergence in the development and expression of the mouse and human antibody repertoires. Dev Comp Immunol (2006) 30:119–35.10.1016/j.dci.2005.06.006
112
ZemlinMBauerKHummelMPfeifferSDeversSZemlinCet alThe diversity of rearranged immunoglobulin heavy chain variable region genes in peripheral blood B cells of preterm infants is restricted by short third complementarity-determining regions but not by limited gene segment usage. Blood (2001) 97:1511–3.10.1182/blood.V97.5.1511
113
HayakawaKAsanoMShintonSAGuiMAllmanDStewartCLet alPositive selection of natural autoreactive B cells. Science (1999) 285:113–6.10.1126/science.285.5424.113
114
HayakawaKCarmackCEHymanRHardyRR. Natural autoantibodies to thymocytes: origin, VH genes, fine specificities, and the role of Thy-1 glycoprotein. J Exp Med (1990) 172:869–78.10.1084/jem.172.3.869
115
ValeAMCavazzoniCBNobregaASchroederHWJr. The global self-reactivity profile of the natural antibody repertoire is largely independent of germline DH sequence. Front Immunol (2016) 7:296.10.3389/fimmu.2016.00296
116
ValeAMKapoorPSkibinskiGAElgavishAMahmoudTIZemlinCet alThe link between antibodies to OxLDL and natural protection against pneumococci depends on D(H) gene conservation. J Exp Med (2013) 210:875–90.10.1084/jem.20121861
Summary
Keywords
natural antibody, antibodies, natural antibody repertoire, B-1 cells, B cell subsets, B cells
Citation
Holodick NE, Rodríguez-Zhurbenko N and Hernández AM (2017) Defining Natural Antibodies. Front. Immunol. 8:872. doi: 10.3389/fimmu.2017.00872
Received
27 April 2017
Accepted
10 July 2017
Published
26 July 2017
Volume
8 - 2017
Edited by
Harry W. Schroeder, University of Alabama at Birmingham, United States
Reviewed by
Andre M. Vale, Federal University of Rio de Janeiro, Brazil; Michael Zemlin, Universitätsklinikum des Saarlandes, Germany
Updates
Copyright
© 2017 Holodick, Rodríguez-Zhurbenko and Hernández.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Nichol E. Holodick, nichol.holodick@med.wmich.edu; Ana María Hernández, anita@cim.sld.cu
Specialty section: This article was submitted to B Cell Biology, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.